Here you will find the recommendations we have made about the use of individual medicines in Lancashire.


Brand: Steglatro®
NICE TA: 572
Indication: Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes (TA572)
Disease category: Endocrine system
Commissioning responsibility: CCG
PbR excluded: No


1.1 Ertugliflozin as monotherapy is recommended as an option for treating type 2 diabetes in adults for whom metformin is contraindicated or not tolerated and when diet and exercise alone do not provide adequate
glycaemic control, only if:

• a dipeptidyl peptidase 4 (DPP 4) inhibitor would otherwise be prescribed and

• a sulfonylurea or pioglitazone is not appropriate.


LMMG recommendation: Green (Restricted)
Click here to find the definitions for the colour classifications

Reason for decision:  Suitable for initiation in primary care in line with restrictions

Supporting documents:

NICE TA572 - Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG


Green (Restricted)

Green (Restricted)

Green (restricted)

Green (Restricted)